Ticker brief

CATX

last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
8
authors 14d
5
crowd 14d
+0.42

No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.

Sentiment — last 14 days
daily mean sentiment, 2026-10-04 → 2026-10-09 · now +0.35 (−1 bearish … +1 bullish)
Who spoke5
authorgradetrader scoresignalsmean sent
@PrismMarketViewC·3+0.20
@BiopharmIQB·2+0.22
@BioStocksC-1.771+0.50
@OzmosiHealthC·1+0.50
@PrismDMA-2.761+0.35
Recent signals8of 8 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-10-09@BiopharmIQ+0.35Weekly biotech event roundup covering acquisition, clinical data, FDA status, licensing, and a trial miss.·
2026-10-08@PrismDM+0.35FDA granted Fast Track designation to PSV359; the tweet clarifies this is not approval.·
2026-10-08@PrismMarketView+0.40Reports FDA Fast Track designation for an investigational solid-tumor therapy.·
2026-10-08@OzmosiHealth+0.50Drug candidate received FDA Fast Track designation for a rare tumor indication.·
2026-10-08@PrismMarketView+0.10CATX will present safety and efficacy data for VMT-α-NET at NANETS 2026.·
2026-10-08@BioStocks+0.50PSV359 received FDA Fast Track designation for FAP-positive solitary fibrous tumors.·
2026-10-07@BiopharmIQ+0.10Summarizes positive midday biotech stock moves alongside company catalysts.·
2026-10-04@PrismMarketView+0.10Lists upcoming clinical readouts, presentations, filings, and pivotal-trial milestones.·

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.